A new study describes a model that estimates the economic consequences of using the T2Candida Panel (a novel diagnostic product that provides Candida detection) as an adjunct to the current blood culture-based diagnostic strategy in a high-risk hospital patient cohort.
from The Medical News http://ift.tt/1Fpmjk5
from The Medical News http://ift.tt/1Fpmjk5
No comments:
Post a Comment